Individuals with germline ETV6 mutations are reported to be at increased risk for all hematologic malignancies, including MDS, AML, CMML, B-lymphoblastic leukemia, and plasma cell myeloma. The gene discussed is ETV6; the disease is acute myeloid leukemia.